ASCEND-TD: A Randomized, Double-Blind, Active-Controlled Study of Daprodustat Administered Three Times Weekly in Hemodialysis Patients
Coyne D, Singh A, Lopes R, Bailey C, Dimino T, Huang C, Connaire J, Rastogi A, Kim S, Orias M, Shah S, Patel V, Cobitz A, Wanner C. ASCEND-TD: A Randomized, Double-Blind, Active-Controlled Study of Daprodustat Administered Three Times Weekly in Hemodialysis Patients. Journal Of The American Society Of Nephrology 2021, 32: 191-191. DOI: 10.1681/asn.20213210s1191b.Peer-Reviewed Original ResearchDouble-blindHemodialysis patients